Form 8-K - Current report:
SEC Accession No. 0001104659-21-034749
Filing Date
2021-03-11
Accepted
2021-03-11 07:34:08
Documents
2
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218044d2_8k.htm 8-K 18313
2 EXHIBIT 99.1 tm218044d2_ex99-1.htm EX-99.1 61093
  Complete submission text file 0001104659-21-034749.txt   80501
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 21731864
SIC: 2834 Pharmaceutical Preparations